Could a cancer drug cut surgeries for rare throat condition?
NCT ID NCT05797246
First seen Oct 31, 2025 · Last updated May 14, 2026 · Updated 23 times
Summary
This study tests if the drug bevacizumab can help adults with a rare condition called recurrent respiratory papillomatosis (RRP), which causes wart-like growths in the airways that often need repeated surgeries. About 21 participants will receive the drug through an IV after surgery to see if it lengthens the time between needed surgeries. The goal is to reduce how often people need operations to keep their airways clear.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFECTIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
Conditions
Explore the condition pages connected to this study.